Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 816

1.

A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia.

Hong CJ, Chen JY, Chiu HJ, Sim CB.

Int Clin Psychopharmacol. 1997 May;12(3):123-30.

PMID:
9248867
2.

The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.

Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Stern RG, Losonczy MF.

J Clin Psychiatry. 1999 Jan;60(1):41-4. Erratum in: J Clin Psychiatry 1999 May;60(5):341.

PMID:
10074877
3.

The risks and benefits of clozapine versus chlorpromazine.

Claghorn J, Honigfeld G, Abuzzahab FS Sr, Wang R, Steinbook R, Tuason V, Klerman G.

J Clin Psychopharmacol. 1987 Dec;7(6):377-84.

PMID:
3323261
4.

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.

Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.

Arch Gen Psychiatry. 2001 Oct;58(10):965-72.

PMID:
11576036
5.

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.

J Clin Psychiatry. 2005 Jan;66(1):63-72.

PMID:
15669890
6.

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Kane J, Honigfeld G, Singer J, Meltzer H.

Arch Gen Psychiatry. 1988 Sep;45(9):789-96.

PMID:
3046553
7.
8.

Clozapine efficacy in tardive dyskinesia in schizophrenic patients.

Bassitt DP, Louzã Neto MR.

Eur Arch Psychiatry Clin Neurosci. 1998;248(4):209-11.

PMID:
9810484
9.

Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.

Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.

J Clin Psychiatry. 1997 Jul;58(7):318-22.

PMID:
9269253
10.

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.

de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.

J Clin Psychiatry. 2009 Oct;70(10):1416-23. doi: 10.4088/JCP.08m04935gry. Erratum in: J Clin Psychiatry. 2011 Aug;72(8):1157.

PMID:
19906345
11.

Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.

Klieser E, Lehmann E, Kinzler E, Wurthmann C, Heinrich K.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):45S-51S.

PMID:
7537287
12.

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr.

Am J Psychiatry. 1994 Jan;151(1):20-6.

PMID:
8267129
13.

Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.

Shopsin B, Klein H, Aaronsom M, Collora M.

Arch Gen Psychiatry. 1979 Jun;36(6):657-64.

PMID:
375865
14.
15.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
16.

Response to clozapine in acute mania is more rapid than that of chlorpromazine.

Barbini B, Scherillo P, Benedetti F, Crespi G, Colombo C, Smeraldi E.

Int Clin Psychopharmacol. 1997 Mar;12(2):109-12.

PMID:
9219046
17.

The effects of clozapine on symptom clusters in treatment-refractory patients.

Abraham G, Nair C, Tracy JI, Simpson GM, Josiassen RC.

J Clin Psychopharmacol. 1997 Feb;17(1):49-53.

PMID:
9004057
19.

Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.

Kim Y, Kim BN, Cho SC, Kim JW, Shin MS.

Hum Psychopharmacol. 2008 Dec;23(8):715-22. doi: 10.1002/hup.982.

PMID:
18814190
20.

Supplemental Content

Support Center